NCT00773279 Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics Status COMPLETED Phase PHASE3
NCT00771680 Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes Status COMPLETED Phase N/A
NCT00763412 Pilot and Feasibility Study for the Treatment of Pre-diabetes in Patients With Cystic Fibrosis Status COMPLETED Phase NA
NCT00761540 To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo Status COMPLETED Phase PHASE1
NCT00760448 Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia Status COMPLETED Phase PHASE1
NCT00755833 Observational Study of NovoMix® 50 for Treatment of Type 2 Diabetics for 12 Months Status COMPLETED Phase N/A
NCT00747409 Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes Status UNKNOWN Phase PHASE4
NCT00745433 Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide Status COMPLETED Phase N/A
NCT00740519 Observational Study on Safety of Self-titration of Once Daily Levemir® Status COMPLETED Phase N/A
NCT00738153 An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Status COMPLETED Phase N/A
NCT00737776 Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes Status COMPLETED Phase N/A
NCT00735501 Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes Status COMPLETED Phase N/A
NCT00729898 Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes Status COMPLETED Phase N/A
NCT00728455 Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers Status WITHDRAWN Phase PHASE1
NCT00725036 Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT00722540 Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Status COMPLETED Phase PHASE1
NCT00717288 Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir Status COMPLETED Phase PHASE4
NCT00715780 Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents Status COMPLETED Phase N/A
NCT00715689 Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Status COMPLETED Phase PHASE2
NCT00715663 Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes Status COMPLETED Phase N/A